Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Calidi Biotherapeutics (CLDI)
NYSE MKT:CLDI
RESEARCH TOOLSreports
Holding CLDI?
Track your performance easily
See the Price Targets and Ratings of:
CLDI Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CLDI Stock 12 Month Forecast
Average Price Target
$2.50
▲(16.82% Upside)
| Highest Price Target$2.50 | Average Price Target$2.50 | Lowest Price Target$2.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Robert W. Baird
Initiated
11/17/24
Ladenburg Thalmann & Co.
$10
Buy
367.29%
Upside
Initiated
06/27/24
Calidi initiated with a Buy at LadenburgCalidi initiated with a Buy at Ladenburg
H.C. Wainwright
$20
Buy
834.58%
Upside
Reiterated
03/21/24
Optimistic Outlook for Calidi Biotherapeutics Despite Financial Hurdles: A Buy Rating Justified by Promising Oncology Pipeline
Unknown Analyst
Not Ranked
Rodman & Renshaw
$10
Buy
367.29%
Upside
Initiated
06/27/24
Rodman Renshaw starts Calidi Biotherapeutics Inc (CLDI) at BuyRodman Renshaw initiates coverage on Calidi Biotherapeutics Inc (NYSE: CLDI) with a Buy rating and a price target of $1.00.
Best Analysts Covering Calidi Biotherapeutics
Which Analyst Should I Follow If I Want to Buy CLDI and Sell After:
1 Month
xxx
Success Rate
1/3 ratings generated profit
Average Return
-24.97%
initiated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of -24.97% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
Average Return
-47.20%
initiated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -47.20% per trade.
1 Year
Success Rate
1/3 ratings generated profit
Average Return
-49.97%
initiated a buy rating 7 days ago
Copying Joel Beatty's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -49.97% per trade.
2 Years
xxx
Success Rate
1/3 ratings generated profit
Average Return
-49.80%
initiated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -49.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CLDI Analyst Recommendation Trends
Rating
Nov 23
Mar 24
May 24
Jun 24
Sep 24
Strong Buy
3
5
5
5
3
Buy
0
0
0
0
0
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
5
5
5
4
Each month's total comprises the sum of three months' worth of ratings.
CLDI Financial Forecast
CLDI Stock Forecast FAQ
What is CLDI’s average 12-month price target, according to analysts?
Based on analyst ratings, Calidi Biotherapeutics’s 12-month average price target is $2.50.
What is CLDI’s upside potential, based on the analysts’ average price target?
Calidi Biotherapeutics has 16.82% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CLDI a Buy, Sell or Hold?
Calidi Biotherapeutics has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Calidi Biotherapeutics’s price target?
The average price target for Calidi Biotherapeutics is $2.50. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.50 ,the lowest forecast is $2.50. The average price target represents 16.82% Increase from the current price of $2.14.
The highest analyst price target is $2.50 ,the lowest forecast is $2.50. The average price target represents 16.82% Increase from the current price of $2.14.
What do analysts say about Calidi Biotherapeutics?
Calidi Biotherapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of CLDI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.